Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1201 - 1300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1201 | 26712479 |
BR |
77 | 2 |
Diabetes mellitus, Hypertension, Blood cholesterol increased, Anxiety, Fear, Dyspnoea, Ear infection, Hypoacusis, Back pain, Arthralgia, Arthralgia, Pain in extremity, Pain in extremity, Gait disturbance, Menopausal symptoms, Malaise, Defaecation disorder, |
||||
CLONAZEPAM, |
||||
| 1202 | 26712487 |
US |
1 | |
Hallucination, Fatigue, Constipation, Gait disturbance, Confusional state, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1203 | 26712608 |
CA |
43 | 2 |
Adjustment disorder with depressed mood, Abdominal discomfort, Amnesia, Alopecia, Anxiety, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Breast cancer stage III, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Condition aggravated, Decreased appetite, Delirium, Depression, Diarrhoea, Dislocation of vertebra, Drug intolerance, Dislocation of vertebra, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Ear pain, Fatigue, Fibromyalgia, Gait disturbance, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Joint range of motion decreased, Intentional product use issue, |
||||
LAMOTRIGINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC, DICLOFENAC SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOPIRAMATE, TOPIRAMATE, |
||||
| 1204 | 26712827 |
US |
60 | 2 |
Cerebrovascular accident, Hemiparesis, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1205 | 26713247 |
US |
78 | 1 |
Infection, Balance disorder, Limb discomfort, Throat tightness, Ear congestion, Vomiting, Gait disturbance, Dizziness, Dry eye, General physical health deterioration, Migraine, Product dose omission in error, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, ALBUTEROL SULFATE, ALBUTEROL, ALFUZOSIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BACLOFEN, BACLOFEN, GABAPENTIN, MAGNESIUM, SIMVASTATIN, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 1206 | 26713259 |
US |
81 | 1 |
Deafness, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1207 | 26713428 |
US |
2 | |
Altered state of consciousness, Gait disturbance, Fatigue, Productive cough, Dyspnoea, Blood pressure increased, |
||||
SODIUM OXYBATE, FENTANYL, ALPRAZOLAM, CARVEDILOL, LINACLOTIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROPRANOLOL HYDROCHLORIDE, |
||||
| 1208 | 26713503 |
US |
67 | 1 |
Dyspnoea, Product dose omission issue, Fatigue, Gait disturbance, Pain in extremity, Mobility decreased, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1209 | 26713504 |
US |
57 | 2 |
Rash, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1210 | 26713884 |
US |
60 | 2 |
Gait disturbance, Drooling, Fatigue, Dysphonia, |
||||
DEUTETRABENAZINE, CLONAZEPAM, |
||||
| 1211 | 26714081 |
GB |
41 | 2 |
Crohn^s disease, Product supply issue, Gait disturbance, |
||||
USTEKINUMAB, |
||||
| 1212 | 26714174 |
US |
2 | |
Gait disturbance, Adverse reaction, Abdominal pain upper, Abdominal pain, Chest pain, Back pain, |
||||
ZOLEDRONIC ACID, |
||||
| 1213 | 26714987 |
US |
1 | |
Abdominal discomfort, Gait disturbance, |
||||
TENAPANOR HYDROCHLORIDE, |
||||
| 1214 | 26715515 |
US |
57 | 1 |
Neuropathy peripheral, Loss of consciousness, Product dose omission issue, Wrong technique in product usage process, Headache, Balance disorder, Pain in extremity, Gait disturbance, |
||||
DAROLUTAMIDE, |
||||
| 1215 | 26715553 |
73 | 1 | |
Joint swelling, Arthralgia, Gait disturbance, |
||||
LENALIDOMIDE, |
||||
| 1216 | 26715950 |
JP |
68 | 2 |
Akinesia, Gait disturbance, Balance disorder, Hyponatraemia, Muscle rigidity, Extrapyramidal disorder, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 1217 | 26716386 |
58 | 2 | |
Nausea, Fatigue, Headache, Muscular weakness, Taste disorder, Gait disturbance, Asthenia, Pain, Weight decreased, |
||||
OBINUTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, BENDAMUSTINE HCL, |
||||
| 1218 | 26716753 |
US |
65 | 1 |
Tachycardia, Deep vein thrombosis, Sepsis, Pyrexia, Gait disturbance, Osteoarthritis, Pain, Feeling cold, Blood pressure abnormal, Cellulitis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 1219 | 26716833 |
US |
70 | 2 |
Gait disturbance, Decreased appetite, Nausea, |
||||
PEMBROLIZUMAB, |
||||
| 1220 | 26717218 |
US |
1 | |
Condition aggravated, Gait disturbance, Pain, Insomnia, Muscle spasms, Product ineffective for unapproved use, |
||||
GABAPENTIN, GABAPENTIN, SACUBITRIL AND VALSARTAN, RIVAROXABAN, DAPAGLIFLOZIN, |
||||
| 1221 | 26717243 |
US |
2 | |
Pneumonia, Dyspnoea, Wheezing, Cough, Gait disturbance, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1222 | 26717289 |
US |
49 | |
Surgery, Night blindness, Erythema, Skin ulcer, Unevaluable event, Weight decreased, Gait disturbance, Headache, Visual impairment, Vision blurred, Disease complication, Fatigue, Illness, Dysphonia, |
||||
VUTRISIRAN, VUTRISIRAN, |
||||
| 1223 | 26717632 |
US |
49 | 2 |
Acoustic neuroma, Fungal infection, Feeling abnormal, Nausea, Dyspnoea, Aphonia, Nasal congestion, Cough, Gait disturbance, Tongue pruritus, Back disorder, |
||||
AVAPRITINIB, AVAPRITINIB, AVAPRITINIB, CETIRIZINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 1224 | 26717665 |
US |
65 | 2 |
Fall, C-reactive protein increased, Haematocrit decreased, Hip surgery, Asthenia, Arthritis, Gait disturbance, Cerebral haematoma, Fatigue, Seroma, Loss of consciousness, Sepsis, Haemoglobin decreased, Chills, Surgical failure, Beta haemolytic streptococcal infection, Illness, Head injury, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, |
||||
| 1225 | 26719721 |
68 | 2 | |
Gait disturbance, Dizziness postural, Gastrointestinal haemorrhage, |
||||
AMBRISENTAN, |
||||
| 1226 | 26719936 |
70 | 2 | |
Incontinence, Cognitive disorder, Gait disturbance, Gait disturbance, |
||||
OFATUMUMAB, |
||||
| 1227 | 26720130 |
68 | 2 | |
Gait disturbance, Dizziness postural, Gastrointestinal haemorrhage, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, AMBRISENTAN, |
||||
| 1228 | 26704686 |
CA |
43 | 2 |
Pericarditis, Wound, Live birth, Dyspnoea, Depression, Type 2 diabetes mellitus, Delirium, Bursitis, Blood cholesterol increased, C-reactive protein abnormal, Duodenal ulcer perforation, Abdominal discomfort, Rash, Diarrhoea, Hypoaesthesia, Asthenia, Alopecia, Helicobacter infection, Gait disturbance, Pemphigus, Hypertension, Fatigue, Decreased appetite, Glossodynia, Swelling, Drug intolerance, Hand deformity, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, OXYCODONE HYDROCHLORIDE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOPIRAMATE, TOPIRAMATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, LAMOTRIGINE, RAMIPRIL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 1229 | 26704750 |
21 | 2 | |
Homicidal ideation, Aggression, Grip strength decreased, Gait disturbance, Memory impairment, Suicidal ideation, Product ineffective for unapproved use, Off label use, |
||||
PREGABALIN, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LACOSAMIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PERAMPANEL, BASILIXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, VALPROIC ACID, |
||||
| 1230 | 26704919 |
AR |
70 | 1 |
Syncope, Blood magnesium decreased, Varicose vein, Heart rate increased, Decreased appetite, Skin irritation, Fatigue, Rash pustular, Joint swelling, Skin erosion, Pain in extremity, Gait disturbance, Vomiting, Dry skin, Skin discolouration, Blood pressure increased, Pyrexia, Blood pressure decreased, Angular cheilitis, Oral mucosal eruption, Arthralgia, |
||||
PANITUMUMAB, BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXALIPLATIN, |
||||
| 1231 | 26704929 |
CA |
95 | 1 |
Death, Gait disturbance, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 1232 | 26705723 |
CO |
2 | |
Spinal operation, Fall, Gait disturbance, Balance disorder, Contusion, |
||||
DENOSUMAB, |
||||
| 1233 | 26706374 |
US |
59 | 1 |
Arthralgia, General physical health deterioration, Gait disturbance, |
||||
ABATACEPT, ABATACEPT, |
||||
| 1234 | 26706834 |
US |
2 | |
Renal failure, Gait disturbance, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1235 | 26706878 |
75 | 2 | |
Myalgia, Fatigue, Gait disturbance, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, RIVAROXABAN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 1236 | 26706954 |
US |
||
Somnolence, Brain fog, Gait disturbance, Off label use, |
||||
BINIMETINIB, |
||||
| 1237 | 26707159 |
US |
68 | 2 |
Arthritis, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1238 | 26707363 |
EU |
51 | 2 |
Seizure, Hospitalisation, Hyperhidrosis, Gait disturbance, Depression, Decreased appetite, Anxiety, Agitation, Tremor, Weight increased, Dry mouth, Vomiting, |
||||
LIRAGLUTIDE, BUPROPION HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, ALPRAZOLAM, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, LANSOPRAZOLE, SIMVASTATIN, |
||||
| 1239 | 26707930 |
US |
51 | 2 |
Gait disturbance, Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1240 | 26708018 |
US |
32 | 1 |
Bone pain, Peripheral swelling, Pruritus, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1241 | 26708463 |
US |
54 | |
Hepatotoxicity, Vision blurred, Disorientation, Gait disturbance, Blood triglycerides increased, Fatigue, Pain in extremity, Abnormal dreams, Somnolence, Feeling abnormal, Faeces pale, Abnormal faeces, Rash pruritic, Rash macular, Hepatic enzyme increased, |
||||
RESMETIROM, SALMETEROL XINAFOATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE MAGNESIUM, ESCITALOPRAM, TESTOSTERONE CYPIONATE, ALBUTEROL SULFATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 1242 | 26708642 |
GB |
54 | 1 |
Death, Treatment noncompliance, Intentional product misuse, Fluid retention, Blood iron decreased, Gait disturbance, Accident at home, Weight increased, Constipation, Fall, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, CLONAZEPAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LACTULOSE, RISPERIDONE, QUETIAPINE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 1243 | 26708673 |
US |
75 | 1 |
Gait disturbance, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1244 | 26709039 |
US |
76 | 2 |
Gait disturbance, Pain, |
||||
SARILUMAB, |
||||
| 1245 | 26709071 |
|||
Pain, Gait disturbance, Eating disorder, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 1246 | 26709368 |
US |
2 | |
Pain, Mobility decreased, Gait disturbance, |
||||
SARILUMAB, |
||||
| 1247 | 26709542 |
US |
2 | |
Myalgia, Headache, Muscular weakness, Gait disturbance, |
||||
DUPILUMAB, ZOLPIDEM TARTRATE, CELECOXIB, HYDROCHLOROTHIAZIDE, SITAGLIPTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PAROXETINE HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SIMVASTATIN, TIZANIDINE HYDROCHLORIDE, |
||||
| 1248 | 26709660 |
US |
2 | |
Pain, Malaise, Gait disturbance, |
||||
SARILUMAB, SARILUMAB, |
||||
| 1249 | 26709820 |
US |
2 | |
Drug withdrawal syndrome, Headache, Nausea, Dizziness, Gait disturbance, Fall, Malaise, |
||||
PREGABALIN, |
||||
| 1250 | 26709824 |
30 | ||
Epilepsy, Petit mal epilepsy, Gait disturbance, Dizziness, Headache, Visual impairment, Hyperacusis, Photophobia, Agoraphobia, Acrophobia, Vertigo, Skin disorder, Asthenia, Fatigue, Drug ineffective, |
||||
LEVETIRACETAM, |
||||
| 1251 | 26709967 |
US |
62 | 2 |
Renal failure, Pain, Gait disturbance, Renal impairment, Liver function test increased, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 1252 | 26710213 |
GB |
85 | |
Localised infection, Dizziness, Illness, Gait disturbance, Dyspnoea, Temperature intolerance, Product administered by wrong person, |
||||
VUTRISIRAN, |
||||
| 1253 | 26710237 |
US |
34 | 1 |
Somnolence, Gait disturbance, Weight increased, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 1254 | 26711127 |
US |
2 | |
Gait disturbance, Sleep apnoea syndrome, Osteopenia, Osteoporosis, Arthralgia, |
||||
| 1255 | 26711388 |
EU |
82 | 2 |
Umbilical hernia, Gait disturbance, Motor dysfunction, Ileus, Mental disorder, Poor quality sleep, |
||||
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, CLOPIDOGREL, MEMANTINE, MEMANTINE HYDROCHLORIDE, MIRTAZAPINE, CLOBAZAM, ATORVASTATIN CALCIUM, NEBIVOLOL HYDROCHLORIDE, PRAMIPEXOLE, |
||||
| 1256 | 26711423 |
US |
69 | 2 |
Hospitalisation, Ulcer, Complication associated with device, Pruritus, Sitting disability, Eczema, Allergy to animal, Skin haemorrhage, Pruritus allergic, Somnolence, Pain, Therapeutic product effect incomplete, Erythema, Biopsy, Gait disturbance, Pain in extremity, Rash macular, Cellulitis, Medical device implantation, Peripheral swelling, |
||||
UPADACITINIB, HYDROXYZINE, |
||||
| 1257 | 26714693 |
87 | 1 | |
Pain in extremity, Gait disturbance, |
||||
EZETIMIBE, |
||||
| 1258 | 26716498 |
2 | ||
Seizure, Limb discomfort, Gait disturbance, |
||||
LAROTRECTINIB, LEVETIRACETAM, |
||||
| 1259 | 26703057 |
EU |
61 | 1 |
Computerised tomogram dental, Tooth disorder, Growth of eyelashes, Absence to tonic clonic seizure, Eosinophil count, Eosinophil count decreased, Eosinophil count increased, Ectopic atrial rhythm, Myeloproliferative neoplasm, Accidental exposure to product, ACKR1 gene polymorphism, Acquired renal arteriovenous fistula, Enteritis necroticans, Enteritis necroticans, Acylcarnitine profile, Neutropenic colitis, Neutropenic colitis, Air in device issue, Airway endoscopy, Alpha-L-fucosidase test, Analytical testing repeated without appropriate rationale, Haemangioma, Haemangioma, Anorectal wound, Ligament injury, Vaginal prolapse, Anti-JC virus antibody positive, Antinuclear antibody negative, Antinuclear antibody positive, Drug ineffective, Aortic dilatation, APOL1 gene mutation, Apolipoprotein C-III increased, Appendicolith, Appendicolith, Encephalitis viral, Arrhythmogenic cardiomyopathy, Ultrasound Doppler, Arteriovenous graft placement, Arteriovenous graft removal, Aseptic process simulation issue, Aspartate beta-hydroxylase increased, Aspergillus otitis externa, Aspartate beta-hydroxylase increased, Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits, Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits, Cerebral haemorrhage, Cerebral haemorrhage, Spinal osteoarthritis, Cardiac ablation, Atrial electromechanical dissociation, Atrial fibrillation conversion pause, Cholecystitis chronic, Autoimmune pleuritis, Autosomal dominant hypocalcaemia type 1, Autosomal dominant hypocalcaemia type 1, B-cell malignancy, Bacillus test, Bacterospermia, Beighton score, Dyskinesia, Benign familial infantile epilepsy, Benign neoplasm progression, BI-RADS abnormal, BI-RADS incomplete, BI-RADS negative, Carpal tunnel syndrome, Bilateral tonic clonic seizure, Bile reflux gastropathy, Biliary candidiasis, Drug delivery device placement, Device dislocation, Ocular drug delivery device placement, Device dislocation, Device dislocation, Device dislocation, Myeloproliferative neoplasm transformation, Ureteroneocystostomy, BRAF gene mutation, Amygdalotomy, Contraception breakthrough bleeding, Breast adenosis, Breast candidiasis, BI-RADS abnormal, BI-RADS incomplete, BI-RADS negative, Breast operation, Respiratory rate, Anticoagulant therapy, BRIP1 gene mutation, Thinking abnormal, Ileostomy, Brucellosis, Burning sensation, Localised oedema, Localised oedema, Bone erosion, Candida infection, Breast candidiasis, Cardiac allograft vasculopathy, Cardiac complication associated with device, Carotid artery pseudoaneurysm, Hepatectomy, Coeliac artery dissection, Cell bank management issue, Cell bank management issue, Cell bank management issue, Cell bank management issue, Cell bank management issue, Cell bank management issue, Cell bank management issue, Cell bank management issue, Cell bank issue, Cell bank management issue, Cell bank issue, Cell bank management issue, Cell culture production issue, Cephalhaematoma excision, Cephalhaematoma excision, Cerebral atrophy, Thrombocytopenia, Cholecystokinin-cholescintigraphy, Chronic histiocytic intervillositis, Creatine kinase decreased, Creatine kinase MB abnormal, Creatine kinase MB normal, Coeliac artery dissection, Complexion-associated melanosis, Complication associated with device, Complication associated with device, Eye complication associated with device, Eye complication associated with device, Manufacturing validation issue, Computerised tomogram of gallbladder abnormal, Manufacturing validation issue, Computerised tomogram of gallbladder abnormal, Concern of disease stigma, Congenital musculoskeletal disorder of limbs, Congenital floppy infant, Contaminated product administered, Contraception breakthrough bleeding, Corneal epithelium injury, Coronary artery thrombectomy, Creatine kinase BB, Creatine kinase BB increased, Creatine kinase MB abnormal, Creatine kinase MB decreased, Creatine kinase MM decreased, Creatine kinase MM increased, Vanishing white matter disease, Gait disturbance, Visually induced motion sickness, CDKL5 deficiency disorder, Cytolethal distending toxin positive, Cytomegalovirus test, Pneumonia cytomegaloviral, Cytomegalovirus respiratory tract infection, Stoma creation, Angioedema, Dengue post vaccine, Dengue post vaccine, Dental pulp exposure, Hyperaesthesia teeth, Developmental and epileptic encephalopathy with spike-and-wave activation in sleep, Device computer issue, Device information output issue, Product contamination, Device temperature production issue, Device temperature production issue, Device signal transmission issue, Device malfunction, Device dispensing issue, Device electromagnetic compatibility issue, Device electrical finding, Device output issue, Device safety feature issue, Device filtration issue, Device output issue, Device temperature production issue, Device temperature production issue, Device incompatibility issue, Device malfunction, Device optical issue, Device material issue, Device mechanical parts lubrication issue, Device mechanical parts lubrication issue, Device physical property issue, Device computer issue, Device optical issue, Device optical issue, Device optical issue, Device optical issue, Device optical issue, Device placement error, Device programming issue, Device output issue, Device information output issue, Device temperature production issue, Dialysis access removal, Diastolic hyperaemia-free ratio, Diastolic hyperaemia-free ratio, Device power source issue, Autoscopy, Product use complaint, Distal femoral replacement, Polyneuropathy, Donor leukocyte infusion, Dosing error, Drug effect more than expected, Product ineffective for unapproved use, Drug titration issue, Product use issue, ACKR1 gene polymorphism, Duplicate therapy issue, Dyskeratosis, Dysmorphic urinary red blood cells, Dysorthography, Ear culture, Ear culture, Early infantile developmental and epileptic encephalopathy, Early infantile developmental and epileptic encephalopathy, Dissociation, Elastofibroma, Enlarged vestibular aqueduct, Enterography, Eosinophilic bronchiolitis, Epigenetic change, Epileptic negative myoclonus, Manufacturing qualification issue, Hypoxia, Experience of insightfulness, Spiritual experience, External manufacturing supply management issue, External supplier qualification issue in manufacturing, Jeavons syndrome, Jeavons syndrome, Back pain, Multiple self-healing squamous epithelioma, Intrauterine transfusion, Radiation skin injury, Flank discomfort, Fluorescent in situ hybridisation, Focal dyscognitive seizures, Simple partial seizures, Intrauterine transfusion, Foreign body in respiratory tract, Sputum abnormal, Fungal test, Gastrolithiasis, Gastroduodenal artery embolisation, Gastroduodenal artery embolisation, Gastrointestinal stromal tumour malignant, Gastrointestinal stromal tumour malignant, Gene therapy, Infantile spasms, Infantile spasms, Genital abscess male, Gestational hypothyroidism, Glasgow-Imrie score, Glomerulonephropathy, Gluteal herpes simplex infection, Greater trochanteric pain syndrome, Graft versus host disease of the kidney, Parakeratosis, Inguinal ultrasound, Gingival injury, Tenosynovitis, Allogenic stem cell transplantation, HCN1 gene mutation, Humerus fracture, Osteochondrosis, Hepatic flexure mobilisation, Hepatic flexure mobilisation, Haemangioma of liver, Haemangioma of liver, Hepatic vein haemorrhage, Hepatic vein haemorrhage, Thyroid disorder, Pathogen resistance, Proctocolectomy, Ventricular extrasystoles, High grade serous ovarian carcinoma, Histotripsy, Pseudomonas folliculitis, Hyaline occlusive glomerular microangiopathy, Hydronephrosis, Enterography, Hyperthyroidism, Ictal paresis, Colitis, Colitis, Arterioenteric fistula, Impaired maternal-infant bonding, Manufacturing materials issue, Infantile spasms, Inferior vena cava compression, Information technology use disorder, Infrared spectroscopy, Inguinal ultrasound, Psoriasis, Interleukin-2 receptor decreased, Information technology use disorder, Interspinous ligament swelling, Interstitial lung thickening, Intestinal failure, Parenteral nutrition associated liver disease, Intestinal ultrasound, Echocardiogram, Carcinoma in situ, Intrahepatic lymphatic stasis, Intramuscular haemangioma, Intramuscular haemangioma, Intraocular particles, Eye complication associated with device, Intrauterine transfusion, Escherichia infection, Oesophagectomy, Oesophagectomy, Diverticulitis, Joint capsulotomy, Knee torque assessment, Lacrimal canalicular laceration, Prostate adenoma removal, Pharyngeal reconstruction, Left ventricular end-diastolic volume, Leiomyomatosis peritonealis disseminata, Melanocytic naevus, Melanocytic naevus, Meningitis, Achromotrichia acquired, Lhermitte-Duclos disease, Ligament oedema, Ligament oedema, Product storage error, Liposuction, Lipoinjection, Liver venous deprivation procedure, Flank discomfort, Low-luminance deficit, Blepharoplasty, Gambling disorder, Gambling disorder, Supernumerary rib, Macular scar, External manufacturing supply management issue, Osteomyelitis, Manufacturing cell culture management issue, Manufacturing data management system issue, Manufacturing data management system issue, Manufacturing data management system issue, Manufacturing equipment maintenance issue, Manufacturing laboratory controls issue, Manufacturing materials issue, Manufacturing materials issue, Manufacturing qualification issue, Manufacturing validation issue, Metabolic dysfunction-associated steatohepatitis, Metabolic dysfunction-associated liver disease, Maternal body mass index normal, Maternal body mass index normal, Airway secretion clearance therapy, Aseptic process simulation issue, Megaduodenum, Mesenteric resection, Metastases to peritoneum, Arthrodesis, MSI-H/dMMR cancer, Microsomatognosia, Midface hypoplasia, Volvulus of small bowel, Depressed level of consciousness, MSI-H/dMMR cancer, Neuroendocrine tumour, Vitiligo, Mobility decreased, Mobility support, Depressed level of consciousness, APOL1 gene mutation, Morton^s neuralgia, MSI-H/dMMR cancer, Multiple acyl-coenzyme A dehydrogenase deficiency, Multiple self-healing squamous epithelioma, Myeloproliferative neoplasm transformation, Myoclonic tonic clonic seizure, Myosteatosis, Natural killer/T-cell lymphoma, Neovaginal haemorrhage, Neovaginal haemorrhage, Neovaginal haemorrhage, Gastroenteropancreatic neuroendocrine tumour disease, Gastroenteropancreatic neuroendocrine tumour disease, Vitiligo, Norovirus test negative, Ocular drug delivery device placement, Off label use, Omphalith, Onychopapilloma, Optic ataxia, Optic nerve calcification, Oral lichen planus, Hypotonia, Orthosis application, Osteochondroplasty, Parasite stool test, Ovarian vein dilatation, External manufacturing supply management issue, Electrocardiogram P wave, Pachychoroid pigment epitheliopathy, Retinal drusen, Painful lactation, Pruritus, Rash, Papillary thyroid cancer, Tenosynovitis, Hypercalcaemia, Hypercalcaemia, Paroxysmal nocturnal haemoglobinuria, Paroxysmal nocturnal haemoglobinuria, Dermatitis exfoliative, Knee operation, Knee operation, PCDH19 gene-related epilepsy, Pelger-Huet anomaly, Phlebolith, Drain placement, Hyperphantasia, Hallucination, visual, Perceptual disturbance, Perceptual disturbance, Gastrostomy, Portal vein reconstruction, Gastrostomy, Appendiceal abscess, Perineal oedema, Perineal oedema, Periprosthetic joint infection, Tuberous sclerosis complex, Phosphorylated tau increased, Low-level laser therapy, Pruritus, Rash, Peripheral swelling, Metastases to pleura, Polymicrobial sepsis, Myoclonus, Post stroke anxiety, Post-ejaculation urinalysis, Posterior cord syndrome, Ligament operation, Spinal fusion surgery, Spinal fusion surgery, Spinal fusion surgery, Postictal migraine, Premature fontanelle closure, Cerebral atrophy congenital, Product administration issue, Product ineffective for unapproved use, Product selection issue, Product storage issue, Product use in country where product is unapproved, Progressive multifocal leukoencephalopathy associated immune reconstitution inflammatory syndrome, Infection prophylaxis, Pseudo-Pelger-Huet anomaly, Melanocytic naevus, Pseudomonas folliculitis, Pseudomonas test negative, Electrocardiogram P wave, Diffuse alveolar damage, Pulmonary artery filling defect, Pulmonary lymphomatoid granulomatosis, Pulmonary toxocariasis, Gastroenteritis radiation, Stomatitis radiation, Radiation eye injury, Radiation eye injury, Ranson^s score, Anorectal discomfort, Pancreatitis acute, Red cell distribution width, Red cell distribution width, Apathy, RegiSCAR score, Renal cyst, Splenosis, Replication competent retrovirus test, Replication competent retrovirus test, Respiratory gas analysis, Combined immunodeficiency, Retinal ischaemia, Retinal ischaemia, Retinol binding protein abnormal, Rhinitis atrophic, Limb reduction defect, Bronchoscopy, RUCAM score, RUCAM score, Sagging eye syndrome, Spinal deformity, Salivary gland ultrasound, Schwannomatosis, Schwartz-Matsuo syndrome, Scleral depression, Scleral depression, Peripheral nerve neurostimulation, Seborrhoeic melanosis, Seborrhoeic melanosis, Radiation skin injury, Foot deformity, Cerebral atrophy, Diabetes mellitus, Vitiligo, Intestinal mucosal atrophy, Coma, Short telomere syndrome, Cerebellar infarction, Lacunar infarction, Sleeve gastrectomy, Diverticulitis, Skin lesion removal, Sinusitis, Spinal meningeal cyst, Spinal deformity, Spiritual experience, Splenic artery arteriosclerosis, Splenic artery haemorrhage, Splenic artery haemorrhage, Splenic artery arteriosclerosis, Splenic sclerosing angiomatoid nodular transformation, Splenic vein dilatation, Colon cancer, Malignant neoplasm of cornea, Staphylococcal skin infection, Subdural haematoma, Subdural haematoma, Subcapsular hepatic fluid collection, Subclavian artery angioplasty, Periosteal haematoma, Periosteal haematoma, Pulmonary mass, Subretinal injection, Tuberous sclerosis complex, Radiation injury, Superior cluneal nerve entrapment syndrome, Para-umbilical hernia, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Suspected off label use, Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits, Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits, Cerebral haemorrhage, Cerebral haemorrhage, Amyloidosis, Autoinflammatory disease, Hypotension, Hyperaesthesia teeth, Temporoparietooccipital disconnection surgery, Testicular radiotherapy, Arthroscopic surgery, Laparoscopic surgery, Radiation skin injury, Thyroid malformation, Optic nerve cupping, Tracheal deviation, Tracheitis sicca, Transplant associated thrombotic microangiopathy, Traumatic abdominal evisceration, Craniocerebral injury, Syphilis test positive, Massage, Trombiculosis, Interferon gamma release assay positive, Colorectal adenoma, Colitis ulcerative, Unintended device compatibility issue, Urachal calculus, Uraemia odour, Uraemia odour, Urethral polypectomy, Urethral haemorrhage, Urinary bladder haemangioma, Urinary bladder haemangioma, Urinary tract discomfort, Interstitial lung disease, Uterine haemorrhage, Vanishing white matter disease, Tumour invasion, Victim of bullying, Victim of chemical submission, Viral test, Perceptual disturbance, Visually induced motion sickness, Vitreous floaters, Hyperphantasia, Vocal cord cyst removal, Vulvoplasty, Pacemaker generated rhythm, Mobility support, Mobility support, Osteopenia, Wrong technique in product usage process performed in error, Retinitis pigmentosa, |
||||
DOCUSATE SODIUM, FENTANYL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TAPENTADOL HYDROCHLORIDE, PREGABALIN, PREGABALIN, |
||||
| 1260 | 26703140 |
2 | ||
Dyspnoea, Seizure, Vomiting, Headache, Pain, Asthenia, Gait disturbance, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 1261 | 26703239 |
US |
77 | 1 |
Muscle tightness, Gait disturbance, Back pain, Off label use, |
||||
ENZALUTAMIDE, ENZALUTAMIDE, |
||||
| 1262 | 26703403 |
CA |
65 | 2 |
Lower respiratory tract infection, Cough, Respiratory tract congestion, Pain, Malaise, Pruritus, Gait disturbance, Back pain, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, HALOBETASOL PROPIONATE, |
||||
| 1263 | 26703479 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Adverse event, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Autoimmune disorder, Back disorder, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Bursitis, Breast cancer stage III, C-reactive protein abnormal, Chest pain, C-reactive protein increased, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Fluid retention, Folliculitis, Frequent bowel movements, Gait disturbance, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Pruritus, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Myositis, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Night sweats, Oedema, Oedema peripheral, Osteoarthritis, No adverse event, Pain, Pain in extremity, Pancreatitis, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Obesity, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, mixed type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, X-ray abnormal, Laboratory test abnormal, Maternal exposure during pregnancy, Overlap syndrome, Drug ineffective, Drug intolerance, Intentional product misuse, Intentional product use issue, Off label use, Product quality issue, Product use in unapproved indication, Therapy non-responder, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 1264 | 26704677 |
AR |
73 | 2 |
Arrhythmia, Drug ineffective, Poor peripheral circulation, Joint swelling, Peripheral swelling, Gait disturbance, Intentional product misuse, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 1265 | 26701382 |
JP |
8 | 1 |
Pneumonia bacterial, Immune-mediated adrenal insufficiency, Arthralgia, Gait disturbance, Nervous system disorder, Bronchitis, Pain in extremity, |
||||
IPILIMUMAB, NIVOLUMAB, |
||||
| 1266 | 26701393 |
EU |
79 | 1 |
Encephalitis, Somnolence, Disorientation, Gait disturbance, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, RAMUCIRUMAB, |
||||
| 1267 | 26701900 |
US |
77 | 1 |
General physical health deterioration, Pain, Gait disturbance, |
||||
ABATACEPT, |
||||
| 1268 | 26701907 |
US |
91 | 1 |
Neutropenia, Monoclonal gammopathy, Back pain, Auditory disorder, Confusional state, Feeling abnormal, Arthralgia, Pain in extremity, Anaemia, Product supply issue, Therapy interrupted, Epigastric discomfort, Diarrhoea, Blood calcium decreased, Pain, Flatulence, Bone pain, Tooth disorder, Abdominal distension, Skin laceration, Soft tissue disorder, Condition aggravated, Constipation, Nausea, Abdominal pain, Gastrointestinal motility disorder, Defaecation urgency, Faeces soft, Tooth loss, Abdominal pain upper, Faeces pale, Renal cyst, Musculoskeletal discomfort, Arthritis, Blood glucose increased, Injury, Shoulder fracture, Dyspnoea, Nasopharyngitis, Gingival bleeding, Gait disturbance, Cataract, Impaired quality of life, Mobility decreased, Somnolence, Hypophagia, Musculoskeletal pain, Abdominal discomfort, Skin fragility, Skin abrasion, Erythema, Bowel movement irregularity, Weight decreased, Skin wound, Decreased appetite, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CICLOPIROX, FAMOTIDINE, FINASTERIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ONDANSETRON HYDROCHLORIDE, OXYBUTYNIN CHLORIDE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE TABLETS 250 MG, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 1269 | 26702017 |
US |
42 | 2 |
Urinary tract infection, Illness, Insomnia, Limb discomfort, Gait disturbance, Diarrhoea, Vomiting, |
||||
NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE, UBLITUXIMAB, UBLITUXIMAB, |
||||
| 1270 | 26702534 |
BR |
2 | |
Vomiting, Dental caries, Toothache, Pain, Syncope, Vomiting, Hyperthyroidism, Cataract, Glaucoma, Seizure, Cataract, Visual impairment, Thyroid cancer, Second primary malignancy, Neoplasm malignant, Delirium, Perineal disorder, Gait disturbance, Food refusal, Gastrointestinal disorder, Salivary hypersecretion, Eye inflammation, Peripheral swelling, Skin wrinkling, Tooth injury, Blood calcium decreased, Abnormal faeces, Weight increased, Weight decreased, Malaise, Constipation, Fatigue, Asthenia, Pruritus, Nausea, Dry skin, Decreased immune responsiveness, Tooth fracture, Urine odour abnormal, Liver disorder, Hair growth abnormal, Rib fracture, Skin discolouration, COVID-19, Neoplasm, Aneurysm, Onychoclasis, Nail bed disorder, Tooth fracture, Confusional state, Feeling abnormal, Ear pain, Pain in jaw, Tooth disorder, Dysstasia, Ill-defined disorder, Depressed mood, Anxiety, Disturbance in attention, Nasopharyngitis, Pharyngitis, Arthralgia, Pruritus, Drug resistance, Depression, Memory impairment, Cystitis, Joint swelling, Pain in extremity, Influenza, Influenza, Productive cough, Eye discharge, Feeling cold, Hypersensitivity, Pruritus, Scratch, Decreased immune responsiveness, Influenza, Pelvic pain, Musculoskeletal chest pain, Osteoarthritis, Alopecia, Hair colour changes, Mobility decreased, Abdominal distension, Influenza, Swelling face, Product use issue, Inappropriate schedule of product administration, Movement disorder, Bone pain, Somnolence, Dizziness postural, Fall, Cerebral disorder, Balance disorder, Skin haemorrhage, Wound, Scab, Formication, Faeces hard, Distractibility, Burning sensation, Vulvovaginal pain, Peripheral swelling, Eye disorder, Bruxism, Wound haemorrhage, Head injury, Dysstasia, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, CARBOXYMETHYLCELLULOSE SODIUM, GABAPENTIN, FULVESTRANT, CALCIUM, LEVOTHYROXINE SODIUM, PHENAZOPYRIDINE, |
||||
| 1271 | 26702717 |
65 | 2 | |
Hypoaesthesia, Paraesthesia, Fatigue, Multiple sclerosis relapse, Visual field defect, Bladder spasm, Fall, Depression, Diplopia, Gait disturbance, |
||||
DALFAMPRIDINE, |
||||
| 1272 | 26702778 |
US |
48 | 1 |
Gait disturbance, Muscular weakness, |
||||
EDARAVONE, EDARAVONE, |
||||
| 1273 | 26703036 |
2 | ||
Adverse drug reaction, Swelling, Peripheral swelling, Skin exfoliation, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, UPADACITINIB, |
||||
| 1274 | 26707294 |
79 | 1 | |
Anaemia, Decreased appetite, Fatigue, Weight decreased, Gait disturbance, Seizure, |
||||
AVACOPAN, |
||||
| 1275 | 26695038 |
EU |
57 | 2 |
Abdominal pain, Tremor, Brain fog, On and off phenomenon, Catheter site related reaction, Dyskinesia, Dizziness, Gait disturbance, Middle insomnia, Catheter site erythema, Catheter site warmth, Catheter site induration, Abnormal dreams, Feeling abnormal, Emotional disorder, Poor quality sleep, Pain, Pneumoperitoneum, Insomnia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1276 | 26695084 |
US |
77 | 2 |
Knee arthroplasty, Gait disturbance, Pain in extremity, Shoulder arthroplasty, Condition aggravated, Musculoskeletal stiffness, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 1277 | 26695104 |
1 | ||
Deafness, Blindness, Gait disturbance, Dysphagia, |
||||
LENALIDOMIDE, |
||||
| 1278 | 26695371 |
CA |
44 | 1 |
Gait disturbance, Depressed mood, Alcohol abuse, Alcohol withdrawal syndrome, Condition aggravated, Decreased appetite, Somnolence, Asthenia, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE, |
||||
| 1279 | 26696131 |
EU |
71 | 2 |
Epilepsy, Communication disorder, Psychomotor retardation, Affect lability, Drug hypersensitivity, Ataxia, Gait disturbance, Tremor, |
||||
LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, METHYLPREDNISOLONE, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 1280 | 26696514 |
EU |
70 | 1 |
Depressed level of consciousness, Infusion site swelling, Infusion site erythema, Rash, Tremor, Muscle spasms, Salivary hypersecretion, Malaise, On and off phenomenon, Fatigue, Muscle rigidity, Dyspnoea, Gait disturbance, Motor dysfunction, Pain in extremity, Therapeutic product effect incomplete, Disturbance in attention, Musculoskeletal stiffness, Dysstasia, Hyperkinesia, Catheter site mass, Loss of personal independence in daily activities, Oedema peripheral, Dyskinesia, Arthralgia, Paraesthesia, Burning sensation, Muscular weakness, Muscle rigidity, Asthenia, Hypoaesthesia, Constipation, Swelling, Hypersensitivity, Localised oedema, Infusion site warmth, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, PRAMIPEXOLE DIHYDROCHLORIDE, |
||||
| 1281 | 26696634 |
EU |
79 | 1 |
Encephalitis, Disorientation, Gait disturbance, Somnolence, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, RAMUCIRUMAB, |
||||
| 1282 | 26696836 |
CN |
71 | 1 |
Dizziness, Asthenia, Gait disturbance, Visual impairment, |
||||
CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, |
||||
| 1283 | 26697025 |
CN |
54 | 1 |
Dizziness, Ataxia, Headache, Speech disorder, Gait disturbance, Product use in unapproved indication, |
||||
CARBAMAZEPINE, |
||||
| 1284 | 26697195 |
US |
2 | |
Hallucination, Balance disorder, Condition aggravated, Diarrhoea, Gait disturbance, Oedema peripheral, Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, BUDESONIDE, CALCIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, HYDROXYCHLOROQUINE, LOPERAMIDE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, RASAGILINE MESYLATE, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, ERGOCALCIFEROL, |
||||
| 1285 | 26697213 |
EU |
84 | 1 |
Pulmonary oedema, Parkinson^s disease, Pneumonia, Dyskinesia, Nocturia, Memory impairment, Loss of personal independence in daily activities, Device issue, Abnormal dreams, Freezing phenomenon, Gait disturbance, Fall, Confusional state, Dyskinesia, |
||||
CARBIDOPA AND LEVODOPA, |
||||
| 1286 | 26697235 |
US |
34 | |
Gait disturbance, Drug level increased, Diplopia, Fatigue, Vision blurred, Product substitution issue, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 1287 | 26697256 |
36 | ||
Fatigue, Gait disturbance, |
||||
QUETIAPINE, QUETIAPINE, QUETIAPINE, QUETIAPINE, QUETIAPINE, |
||||
| 1288 | 26697348 |
US |
71 | 2 |
Blood uric acid increased, Gait disturbance, Peripheral swelling, |
||||
SPARSENTAN, |
||||
| 1289 | 26697650 |
US |
21 | 2 |
Acute hepatic failure, Drug-induced liver injury, Renal tubular necrosis, Acute kidney injury, Condition aggravated, Encephalopathy, Multiple organ dysfunction syndrome, Hepatorenal syndrome, Contraindicated product administered, Generalised tonic-clonic seizure, Suicidal ideation, Drug ineffective, Aggression, Memory impairment, Grip strength decreased, Gait disturbance, Homicidal ideation, Product prescribing issue, |
||||
VALPROIC ACID, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, PREGABALIN, LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PERAMPANEL, PREDNISONE, PREDNISONE, BASILIXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, |
||||
| 1290 | 26697656 |
US |
1 | |
Hallucination, Gait disturbance, Ill-defined disorder, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1291 | 26697659 |
CA |
56 | 2 |
Diabetes mellitus, Condition aggravated, Rheumatoid arthritis, Pemphigus, Hypersensitivity, Fatigue, Swelling, Vomiting, Oedema, Urticaria, Psoriatic arthropathy, Fibromyalgia, Treatment failure, Wheezing, Gait disturbance, Systemic lupus erythematosus, Peripheral swelling, Dislocation of vertebra, Nausea, Rash, Alopecia, Arthropathy, Muscular weakness, Drug intolerance, Prescribed overdose, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ETANERCEPT, LEFLUNOMIDE, RITUXIMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, CELECOXIB, CELECOXIB, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, TOCILIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CORTISONE ACETATE, ADALIMUMAB, CERTOLIZUMAB PEGOL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, TOFACITINIB, TOFACITINIB CITRATE, SULFASALAZINE, DICLOFENAC, DICLOFENAC SODIUM, CALCIUM, |
||||
| 1292 | 26698277 |
CH |
84 | 2 |
Subdural haematoma, Subgaleal haematoma, Haemorrhage intracranial, Fall, Balance disorder, Haemoglobin decreased, Gait disturbance, Headache, |
||||
CANDESARTAN CILEXETIL, CALCIUM CARBONATE, ANTACID, TORSEMIDE, TORSEMIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, RIVAROXABAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 1293 | 26698689 |
US |
74 | 2 |
Muscular weakness, Gait disturbance, Dizziness, Asthenia, |
||||
TERIPARATIDE, |
||||
| 1294 | 26698831 |
GB |
52 | 2 |
Myalgia, Arthralgia, Pain in extremity, Gait disturbance, |
||||
APIXABAN, APIXABAN, |
||||
| 1295 | 26698986 |
CA |
56 | 2 |
Blood pressure increased, Pain, Tooth fracture, Asthma, Infusion related reaction, Epiglottitis, Laryngitis, Ear pain, Hot flush, Neck pain, Oropharyngeal pain, Skin disorder, Paraesthesia, Throat tightness, Muscle spasticity, Musculoskeletal stiffness, Heart rate irregular, Electric shock sensation, Facial pain, Anxiety, Bladder disorder, Sleep disorder, Caffeine allergy, Drug hypersensitivity, Herpes zoster, Neuralgia, Oral herpes, Urinary incontinence, Sinusitis, Hypotension, Vision blurred, Heart rate increased, Fatigue, Headache, Nausea, Pruritus, Headache, Asthenia, Blindness unilateral, Cellulitis, Erythema, Herpes virus infection, Loss of consciousness, Polyp, White blood cell count decreased, Infusion related reaction, Muscle spasms, Gait disturbance, Iron deficiency, Infusion related reaction, Depressed mood, Hypoaesthesia, Constipation, Off label use, Therapeutic response decreased, Abdominal pain, Gastrointestinal disorder, Muscle rigidity, Multiple sclerosis, Odynophagia, Malaise, Back pain, Piloerection, Eye pain, Fatigue, Multiple sclerosis, Back pain, Malaise, Increased tendency to bruise, Infusion related reaction, Reproductive tract disorder, Spinal pain, |
||||
TAMSULOSIN HYDROCHLORIDE, CAFFEINE, CAFFEINE, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, MIRABEGRON, MIRABEGRON, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ONABOTULINUMTOXINA, LACTULOSE, LACTULOSE, ALBUTEROL SULFATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ERGOCALCIFEROL, |
||||
| 1296 | 26699411 |
62 | 2 | |
Cough, Contrast media allergy, Presyncope, Gait disturbance, Musculoskeletal disorder, Nausea, Abdominal pain upper, Dizziness, Pharyngeal swelling, |
||||
GADOBUTROL, |
||||
| 1297 | 26699548 |
85 | 1 | |
Gait disturbance, Back pain, Insomnia, Fatigue, Asthenia, |
||||
REPOSITORY CORTICOTROPIN, RITUXIMAB, |
||||
| 1298 | 26699666 |
MX |
75 | 1 |
Syncope, Ill-defined disorder, Pain in extremity, Sciatica, Peripheral swelling, Tendon pain, Pruritus, Urticaria, Swelling, Sensitive skin, Gait disturbance, Musculoskeletal pain, Skin abrasion, Product use issue, Fall, Malaise, Contusion, |
||||
NILOTINIB, NILOTINIB, |
||||
| 1299 | 26699785 |
US |
83 | |
Oxygen saturation decreased, Blood test abnormal, Urinary retention, Dizziness, Hypotension, Paraesthesia, Muscular weakness, Amnesia, Hypoaesthesia, Confusional state, Malnutrition, Gait disturbance, General physical health deterioration, Muscle spasms, Urine flow decreased, Muscle strength abnormal, Asthenia, Orthostatic hypotension, Dyspnoea, Incorrect dose administered, |
||||
TREPROSTINIL, TREPROSTINIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SACUBITRIL AND VALSARTAN, OXYGEN, 0XYGEN, LEVOTHYROXINE SODIUM, ETHACRYNIC ACID, |
||||
| 1300 | 26699960 |
34 | 2 | |
Blindness transient, Vertigo, Gait disturbance, Muscular weakness, |
||||
FEXOFENADINE HYDROCHLORIDE, CETIRIZINE HCL, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, FEXOFENADINE HCL, CHLORPHENIRAMINE MALEATE, LORATADINE, FLUTICASONE PROPIONATE, CETIRIZINE HYDROCHLORIDE, DIPHENHYDRAMINE HCL 25 MG, ALLERGY RELIEF, TRIAMCINOLONE ACETONIDE, CETIRIZINE HCL 10 MG, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, MOMETASONE FUROATE, LEVOCETIRIZINE DIHYDROCHLORIDE, ONION, APIS MELLIFERA, DROSERA ROTUNDIFOLIA, EUPHRASIA STRICTA, URTICA URENS, LORATADINE 10MG, CETIRIZINE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE 25MG, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, ALLIUM CEPA, APIS MELLIFICA, ARALIA RACEMOSA, BLATTA ORIENTALIS, BOVISTA, CARDUUS MARIANUS, CHELIDONIUM MAJUS, EUPHRASIA OFFICINALAS, GALPHIMIA GLAUCA, HEDERA HELIX, HYDRASTIS CANADENSIS, LUFFA OPERCULATA, NASTURTIUM AQUATICUM, OKOUBAKA, SABADILLA, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE., CETRORELIX ACETATE, CETRORELIX ACETATE FOR INJECTION, FOLLITROPIN, MENOTROPINS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
